跳至主要内容
临床试验/ACTRN12612000299808
ACTRN12612000299808终止2 期

Treatment of Pancreatic Insufficiency Using Creon Compared with Placebo, in Patients with Locally Advanced or Metastatic Pancreatic Cancer: Effect on Weight, Quality of Life, Nutrition and Survival

Calvary Mater Newcastle0 个研究点目标入组 60 人开始时间: 2012年3月15日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Metastatic or locally advanced pancreatic cancer
  • Histologically proven adenocarcinoma; or elevated Ca 19-9 with evidence of a pancreatic mass
  • Able to participate in the assessement schedule
  • Being treated with palliative intent

排除标准

  • Already on pancreatic enzyme replacement for any reason
  • Presence of steatorrhoea
  • Expected survival of less than 2 months
  • Patients who have had resection or radiotherapy with curative intent with no evidence of recurrent disease
  • Hypersensitivity or intolerance to any of the study medications

研究者

相似试验